5-hydroxytryptophan has been researched along with Depression in 97 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty elderly patients (mean age, 68 years) affected by depression were treated with a combination (P3007) containing 3 mg of dihydroergocristine and 100 mg of levo-5-hydroxytryptophan or placebo for 60 days in a double-blind trial." | 9.06 | Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients. ( Rousseau, JJ, 1987) |
| "Through a controlled double-blind study in 30 hospitalized patients affected with endogenous depression, the antidepressant action of the combination of nialamide+l-5-HTP has been evaluated and compared with a control group which only received nialamide (+ placebo)." | 9.04 | 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. ( Aliño, JJ; Gutierrez, JL; Iglesias, ML, 1976) |
| "A double-blind evaluation of the antidepressant efficacy of treatment with a combination of orally administered L-tryptophan (L-TP) and electroconvulsive therapy (ECT) was made in patients suffering from endogenous depression." | 9.04 | Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis. ( D'Elia, G; Lehmann, J; Raotma, H, 1977) |
| "In this review, we address the possible role of the essential amino acid L-tryptophan or its metabolic derivative 5-hydroxytryptophan in the modulation of serotonin (5-hydroxytryptamine) synthesis and thereby in affecting the pathophysiology of central and peripheral nervous system disorders, including depression and irritable bowel syndrome." | 8.82 | Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders. ( Agazzi, A; Anselmi, L; Candura, SM; Cervio, E; De Giorgio, R; De Ponti, F; Di Nucci, A; Tonini, M, 2003) |
| "5 Hydroxytryptophan (5-HTP) and tryptophan are so-called natural alternatives to traditional antidepressants, used to treat unipolar depression and dysthymia." | 8.81 | Tryptophan and 5-hydroxytryptophan for depression. ( Del Mar, C; Shaw, K; Turner, J, 2002) |
| "Trials were included if they were randomized, included patients with unipolar depression or dysthymia, compared preparations of 5-HTP or tryptophan with placebo, and included clinical outcomes assessed by scales assessing depressive symptoms." | 8.81 | Tryptophan and 5-hydroxytryptophan for depression. ( Del Mar, C; Shaw, K; Turner, J, 2001) |
| "5 Hydroxytryptophan (5-HTP) and tryptophan are so-called natural alternatives to traditional antidepressants, used to treat unipolar depression and dysthymia." | 8.81 | Tryptophan and 5-hydroxytryptophan for depression. ( Del Mar, C; Shaw, K; Turner, J, 2001) |
| "Trials were included if they were randomized, included patients with unipolar depression or dysthymia, compared preparations of 5-HTP or tryptophan with placebo, and included clinical outcomes assessed by scales assessing depressive symptoms." | 8.81 | Tryptophan and 5-hydroxytryptophan for depression. ( Del Mar, C; Shaw, K; Turner, J, 2002) |
| "), potentiated the 5-hydroxytryptophan (5-HTP)-induced head twitch responses in mice and antagonized the reserpine-induced hypothermia in rats." | 7.77 | Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative - an investigation using behavioral tests battery of depression. ( Bhatt, S; Gautam, B; Jindal, A; Mahesh, R; Pandey, D, 2011) |
| "Until recently, all drugs used to treat depression appeared to enhance neurotransmission in one or both of these systems, which was used to explain their antidepressant actions (Gelenberg and Klerman, 1978)." | 7.75 | Tyrosine for the treatment of depression. ( Gelenberg, AJ; Gibson, CJ, 1984) |
| " To further investigate a previous postulate that increased serotonergic activity may cause depression, the effects of chronic mianserin administration on 5-HT, its metabolites, and the subtypes of 5-HT receptors were studied." | 7.69 | Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model. ( Akiyoshi, J; Kuranaga, H; Mizobe, Y; Nagayama, H; Nakamura, M; Tsuchiyama, K, 1994) |
| "To test the hypothesis that a new potent and selective 5-HT2 receptor antagonist would be an excellent blocker of D,L-5-hydroxytryptophan (5-HTP)-induced response suppression in an animal model of depression, we administered LY53857 60 min prior to 5-HTP injections into rats working on an operant schedule for milk reinforcement." | 7.67 | Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857). ( Aprison, MH; Fuller, RW; Hingtgen, JN; Mason, NR, 1985) |
| "Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule." | 7.67 | Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. ( Aprison, MH; Hendrie, HC; Hingtgen, JN, 1984) |
| "The treatment with nialamide + l-5-HTP proved to have a shorter delay of onset." | 6.64 | 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. ( Aliño, JJ; Gutierrez, JL; Iglesias, ML, 1976) |
| "Mood disorders and constipation are often comorbid, yet their shared etiologies have rarely been explored." | 5.51 | Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression. ( Bunnett, NW; Caron, MG; Carson, W; Del Colle, A; Israelyan, N; Jacobsen, JPR; Jensen, DD; Latorre, R; Law, K; Li, Z; Luna, RA; Madra, M; Margolis, KG; Park, Y; Rahim, R; Saurman, V; Xing, A, 2019) |
| " It is the immediate precursor of serotonin and is widely available as a dietary supplement, which is well absorbed after an oral dose." | 5.33 | 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. ( Blackwell, AD; Turner, EH, 2005) |
| "Unfortunately, depression is a common side effect of IFN therapy, affecting approximately a third of HCV patients receiving IFN therapy." | 5.33 | 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. ( Blackwell, AD; Turner, EH, 2005) |
| " Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75%)." | 5.27 | Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. ( Aprison, MH; Hendrie, HC; Hingtgen, JN, 1984) |
| "Pretreatment with desipramine (2." | 5.27 | Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857). ( Aprison, MH; Fuller, RW; Hingtgen, JN; Mason, NR, 1985) |
| "Fifty elderly patients (mean age, 68 years) affected by depression were treated with a combination (P3007) containing 3 mg of dihydroergocristine and 100 mg of levo-5-hydroxytryptophan or placebo for 60 days in a double-blind trial." | 5.06 | Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients. ( Rousseau, JJ, 1987) |
| "A double-blind evaluation of the antidepressant efficacy of treatment with a combination of orally administered L-tryptophan (L-TP) and electroconvulsive therapy (ECT) was made in patients suffering from endogenous depression." | 5.04 | Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis. ( D'Elia, G; Lehmann, J; Raotma, H, 1977) |
| "Through a controlled double-blind study in 30 hospitalized patients affected with endogenous depression, the antidepressant action of the combination of nialamide+l-5-HTP has been evaluated and compared with a control group which only received nialamide (+ placebo)." | 5.04 | 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. ( Aliño, JJ; Gutierrez, JL; Iglesias, ML, 1976) |
| "This paper reviews the preclinical and clinical evidence regarding the use of the dietary supplement 5-hydroxytryptophan (5-HTP) for the treatment of depression." | 4.83 | Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. ( Blackwell, AD; Loftis, JM; Turner, EH, 2006) |
| "In this review, we address the possible role of the essential amino acid L-tryptophan or its metabolic derivative 5-hydroxytryptophan in the modulation of serotonin (5-hydroxytryptamine) synthesis and thereby in affecting the pathophysiology of central and peripheral nervous system disorders, including depression and irritable bowel syndrome." | 4.82 | Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders. ( Agazzi, A; Anselmi, L; Candura, SM; Cervio, E; De Giorgio, R; De Ponti, F; Di Nucci, A; Tonini, M, 2003) |
| "Increasing evidence indicates that tryptophan (Trp) metabolism disturbance controls hippocampal 5-hydroxytryptamine (5-HT) and thereby affecting depression-like behavior, in which the gut microbiota (GM) might be involved." | 4.31 | Whey protein isolate attenuates depression-like behavior developed in a mouse model of breast tumor. ( Chen, Y; Guo, M; He, J; Li, Z; Liu, Y; Maitiniyazi, G; Tao, W; Xia, S, 2023) |
| "21]) were associated with higher odds of antepartum depression and 4 metabolites (betaine [OR = =0." | 3.96 | Metabolomic markers of antepartum depression and suicidal ideation. ( Clish, C; Gelaye, B; Larrabure-Torrealva, GT; Mitro, SD; Molsberry, SA; Sanchez, SE; Williams, MA, 2020) |
| " A possible mechanism was explored in the tests of antagonism of reserpine-induced ptosis and hypothermia, and 5-HTP induced head twitch response in mice." | 3.79 | Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice. ( Cui, YL; Ding, SL; Mao, HP; Qi, XJ; Wang, QS, 2013) |
| "5mg/kg), which could antagonize reserpine-induced ptosis and hypothermia, moreover, both of them could elevate the contents of NE, 5-HT in hippocampus as well as NE, 5-HT, DA in striatum significantly." | 3.79 | Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice. ( Cui, YL; Ding, SL; Mao, HP; Qi, XJ; Wang, QS, 2013) |
| "), potentiated the 5-hydroxytryptophan (5-HTP)-induced head twitch responses in mice and antagonized the reserpine-induced hypothermia in rats." | 3.77 | Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative - an investigation using behavioral tests battery of depression. ( Bhatt, S; Gautam, B; Jindal, A; Mahesh, R; Pandey, D, 2011) |
| "Until recently, all drugs used to treat depression appeared to enhance neurotransmission in one or both of these systems, which was used to explain their antidepressant actions (Gelenberg and Klerman, 1978)." | 3.75 | Tyrosine for the treatment of depression. ( Gelenberg, AJ; Gibson, CJ, 1984) |
| " To further investigate a previous postulate that increased serotonergic activity may cause depression, the effects of chronic mianserin administration on 5-HT, its metabolites, and the subtypes of 5-HT receptors were studied." | 3.69 | Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model. ( Akiyoshi, J; Kuranaga, H; Mizobe, Y; Nagayama, H; Nakamura, M; Tsuchiyama, K, 1994) |
| "Acute pretreatment with clinically equivalent doses of antidepressive drugs has been observed to block D,L-5-hydroxytryptophan (5-HTP) induced behavioral depression in rats working on a food-reinforced operant schedule." | 3.67 | Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. ( Aprison, MH; Hendrie, HC; Hingtgen, JN, 1984) |
| "Since reserpine precipitates depression in some hypertensive patients, we tested this drug on our animal model of depression." | 3.67 | Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine. ( Aprison, MH; Brugge, KL; Hingtgen, JN, 1987) |
| "To test the hypothesis that a new potent and selective 5-HT2 receptor antagonist would be an excellent blocker of D,L-5-hydroxytryptophan (5-HTP)-induced response suppression in an animal model of depression, we administered LY53857 60 min prior to 5-HTP injections into rats working on an operant schedule for milk reinforcement." | 3.67 | Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857). ( Aprison, MH; Fuller, RW; Hingtgen, JN; Mason, NR, 1985) |
| "To further test the new hypersensitive postsynaptic serotonin (5-HT) receptor theory of depression bases on or animal model, it was necessary to demonstrate that some of the currently used antidepressive drugs can block D,L-5-hydroxytryptophan (5-HTP) induced depression acting through postsynaptic rather than presynaptic mechanisms." | 3.66 | Postsynaptic action by four antidepressive drugs in an animal model of depression. ( Aprison, MH; Hingtgen, JN; Nagayama, H, 1981) |
| "Rats working on a food-reinforced operant schedule and exhibiting behavioral depression following administration of D,L-5-hydroxytryptophan (5-HTP) were pretreated with one of three drugs: methysergide, fluoxetine, or amitriptyline." | 3.66 | Pre- and postsynaptic serotonergic manipulations in an animal model of depression. ( Aprison, MH; Hingtgen, JN; Nagayama, H, 1980) |
| "The treatment with nialamide + l-5-HTP proved to have a shorter delay of onset." | 2.64 | 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study. ( Aliño, JJ; Gutierrez, JL; Iglesias, ML, 1976) |
| "Depression is a psychiatric disorder with limited therapy options." | 1.72 | β-carboline-independent antidepressant-like effect of the standardized extract of the barks of ( Amariz, IA; Brys, I; Damasceno, TA; Duarte-Filho, LAMS; Massaranduba, ABR; Menezes, PMN; Nishimura, RHV; Ribeiro, LAA; Rolim, LA; Silva, FS, 2022) |
| "Treatment with 5-hydroxytryptophan restores the levels of 5-HT and its precursors in the HpC, improves HpC neurogenesis, and alleviates despair-like symptoms." | 1.56 | Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine. ( Bigot, M; Chevalier, G; Eberl, G; Katsimpardi, L; Lledo, PM; Moigneu, C; Saha, S; Siopi, E, 2020) |
| "Mood disorders and constipation are often comorbid, yet their shared etiologies have rarely been explored." | 1.51 | Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression. ( Bunnett, NW; Caron, MG; Carson, W; Del Colle, A; Israelyan, N; Jacobsen, JPR; Jensen, DD; Latorre, R; Law, K; Li, Z; Luna, RA; Madra, M; Margolis, KG; Park, Y; Rahim, R; Saurman, V; Xing, A, 2019) |
| " It is the immediate precursor of serotonin and is widely available as a dietary supplement, which is well absorbed after an oral dose." | 1.33 | 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. ( Blackwell, AD; Turner, EH, 2005) |
| "Unfortunately, depression is a common side effect of IFN therapy, affecting approximately a third of HCV patients receiving IFN therapy." | 1.33 | 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin. ( Blackwell, AD; Turner, EH, 2005) |
| "Thus amperozide is a potent antagonist of muricidal behaviour (ED50 = 0." | 1.28 | Amperozide and emotional behaviour. ( Christensson, E; Gustafsson, B, 1990) |
| "Pretreatment with desipramine (2." | 1.27 | Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857). ( Aprison, MH; Fuller, RW; Hingtgen, JN; Mason, NR, 1985) |
| " However, possible toxic effects of high and long term use render its clinical use doubtful." | 1.27 | [Serotonin precursors as antidepressive agents: a review]. ( Beckmann, H; Kasper, S, 1983) |
| " Chronic administration of trazodone (2 mg/kg trazodone/day) also resulted in a significant blockade of the 5-HTP effect (75%)." | 1.27 | Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression. ( Aprison, MH; Hendrie, HC; Hingtgen, JN, 1984) |
| " The drug effects on 5-HTP (25 mg/kg) induced behavioral depression were tested by chronic administration using methysergide which is a postsynaptic blocker of 5-HT, or by comparable clinical doses of antidepressant drugs." | 1.27 | Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression. ( Akiyoshi, J; Nagayama, H; Tobo, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (65.98) | 18.7374 |
| 1990's | 6 (6.19) | 18.2507 |
| 2000's | 9 (9.28) | 29.6817 |
| 2010's | 11 (11.34) | 24.3611 |
| 2020's | 7 (7.22) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte-Filho, LAMS | 1 |
| Amariz, IA | 1 |
| Nishimura, RHV | 1 |
| Massaranduba, ABR | 1 |
| Menezes, PMN | 1 |
| Damasceno, TA | 1 |
| Brys, I | 1 |
| Rolim, LA | 1 |
| Silva, FS | 1 |
| Ribeiro, LAA | 1 |
| Hermanns, T | 2 |
| Graf-Boxhorn, S | 1 |
| Poeck, B | 2 |
| Strauss, R | 2 |
| Xia, S | 1 |
| Maitiniyazi, G | 1 |
| Liu, Y | 1 |
| Chen, Y | 1 |
| Guo, M | 1 |
| He, J | 1 |
| Tao, W | 1 |
| Li, Z | 2 |
| Javelle, F | 1 |
| Lampit, A | 1 |
| Bloch, W | 1 |
| Häussermann, P | 1 |
| Johnson, SL | 1 |
| Zimmer, P | 1 |
| Mitro, SD | 1 |
| Larrabure-Torrealva, GT | 1 |
| Sanchez, SE | 1 |
| Molsberry, SA | 1 |
| Williams, MA | 1 |
| Clish, C | 1 |
| Gelaye, B | 1 |
| Meloni, M | 1 |
| Puligheddu, M | 1 |
| Carta, M | 1 |
| Cannas, A | 1 |
| Figorilli, M | 1 |
| Defazio, G | 1 |
| Siopi, E | 1 |
| Chevalier, G | 1 |
| Katsimpardi, L | 1 |
| Saha, S | 1 |
| Bigot, M | 1 |
| Moigneu, C | 1 |
| Eberl, G | 1 |
| Lledo, PM | 1 |
| Ries, AS | 1 |
| Tian, P | 1 |
| Wang, G | 1 |
| Zhao, J | 1 |
| Zhang, H | 1 |
| Chen, W | 1 |
| Israelyan, N | 1 |
| Del Colle, A | 1 |
| Park, Y | 1 |
| Xing, A | 1 |
| Jacobsen, JPR | 1 |
| Luna, RA | 1 |
| Jensen, DD | 1 |
| Madra, M | 1 |
| Saurman, V | 1 |
| Rahim, R | 1 |
| Latorre, R | 1 |
| Law, K | 1 |
| Carson, W | 1 |
| Bunnett, NW | 1 |
| Caron, MG | 1 |
| Margolis, KG | 1 |
| Wang, QS | 1 |
| Ding, SL | 1 |
| Mao, HP | 1 |
| Cui, YL | 1 |
| Qi, XJ | 1 |
| Xie, C | 1 |
| Peng, Z | 1 |
| Zhao, SL | 1 |
| Pan, CY | 1 |
| Guan, LP | 1 |
| Sun, XY | 1 |
| Ostabal Artigas, MI | 1 |
| Fukuda, K | 1 |
| Rajkumar, R | 1 |
| Pandey, DK | 1 |
| Mahesh, R | 2 |
| Radha, R | 1 |
| Diaz, SL | 1 |
| Maroteaux, L | 1 |
| Iezhitsa, IN | 1 |
| Spasov, AA | 1 |
| Kharitonova, MV | 1 |
| Kravchenko, MS | 1 |
| Jindal, A | 1 |
| Gautam, B | 1 |
| Bhatt, S | 1 |
| Pandey, D | 1 |
| KLINE, NS | 2 |
| SACKS, W | 3 |
| SIMPSON, GM | 1 |
| COPPEN, A | 1 |
| SHAW, DM | 1 |
| MALLESON, A | 1 |
| Agazzi, A | 1 |
| De Ponti, F | 1 |
| De Giorgio, R | 1 |
| Candura, SM | 1 |
| Anselmi, L | 1 |
| Cervio, E | 1 |
| Di Nucci, A | 1 |
| Tonini, M | 1 |
| Young, SN | 1 |
| Turner, EH | 2 |
| Blackwell, AD | 2 |
| Loftis, JM | 1 |
| Hughes, ZA | 1 |
| Liu, F | 1 |
| Platt, BJ | 1 |
| Dwyer, JM | 1 |
| Pulicicchio, CM | 1 |
| Zhang, G | 1 |
| Schechter, LE | 1 |
| Rosenzweig-Lipson, S | 1 |
| Day, M | 1 |
| van Praag, HM | 11 |
| de Haan, S | 1 |
| van Praag, H | 1 |
| de Hann, S | 1 |
| Meltzer, HY | 1 |
| Bono, G | 1 |
| Micieli, G | 1 |
| Sances, G | 1 |
| Calvani, M | 1 |
| Nappi, G | 1 |
| Gelenberg, AJ | 1 |
| Gibson, CJ | 1 |
| Beckmann, H | 1 |
| Kasper, S | 1 |
| Hingtgen, JN | 5 |
| Hendrie, HC | 1 |
| Aprison, MH | 5 |
| Westenberg, HG | 1 |
| Thijssen, JH | 1 |
| de Jong, JT | 1 |
| van Hiele, LJ | 1 |
| Nagayama, H | 5 |
| Lôo, H | 1 |
| Zarifian, E | 1 |
| Wirth, JF | 1 |
| Deniker, P | 1 |
| Kline, N | 1 |
| Akiyoshi, J | 2 |
| Tsuchiyama, K | 1 |
| Mizobe, Y | 1 |
| Nakamura, M | 1 |
| Kuranaga, H | 1 |
| Meyers, S | 1 |
| Shaw, K | 2 |
| Turner, J | 2 |
| Del Mar, C | 2 |
| Trimble, M | 1 |
| Chadwick, D | 1 |
| Reynolds, EH | 1 |
| Marsden, CD | 1 |
| Benkert, O | 1 |
| Luchins, D | 1 |
| Tachiki, KH | 1 |
| Takagi, A | 1 |
| Tateishi, T | 1 |
| Kido, A | 1 |
| Nishiwaki, K | 1 |
| Nakamura, E | 1 |
| Takahashi, R | 3 |
| Praag, HM | 1 |
| Wirz-Justice, A | 3 |
| Nakajima, T | 1 |
| Konishi, H | 1 |
| Zarcone, VP | 1 |
| Berger, PA | 1 |
| Brodie, KH | 1 |
| Sack, R | 1 |
| Barchas, JD | 1 |
| D'Elia, G | 2 |
| Lehmann, J | 1 |
| Raotma, H | 2 |
| Angst, J | 1 |
| Woggon, B | 1 |
| Schoepf, J | 1 |
| Hanson, L | 1 |
| Kirkegaard, C | 1 |
| Bjørum, N | 1 |
| Cohn, D | 1 |
| Faber, J | 1 |
| Lauridsen, UB | 1 |
| Nekup, J | 1 |
| Mitsunobu, K | 1 |
| Aliño, JJ | 1 |
| Gutierrez, JL | 1 |
| Iglesias, ML | 1 |
| Roos, BE | 2 |
| Takahashi, S | 4 |
| Kondo, H | 1 |
| Kato, N | 1 |
| Clark, JA | 1 |
| Clark, MS | 1 |
| Palfreyman, ES | 1 |
| Palfreyman, MG | 1 |
| Korf, J | 5 |
| Masumura, I | 2 |
| Miike, A | 2 |
| Joly, P | 1 |
| Lampert, A | 1 |
| Thomine, E | 1 |
| Lauret, P | 1 |
| Bovier, P | 1 |
| Dick, P | 1 |
| Asnis, GM | 1 |
| Kahn, RS | 1 |
| Brown, SL | 1 |
| Korn, M | 1 |
| Friedman, JM | 1 |
| Wetzler, S | 1 |
| Sandyk, R | 1 |
| Gustafsson, B | 1 |
| Christensson, E | 1 |
| Rousseau, JJ | 1 |
| Tobo, M | 1 |
| Brugge, KL | 1 |
| Fuller, RW | 1 |
| Mason, NR | 1 |
| Persson, T | 1 |
| Fujiwara, J | 1 |
| Otsuki, S | 1 |
| Spooner, CE | 1 |
| Mandell, AJ | 1 |
| Winters, WD | 1 |
| Sabbot, IM | 1 |
| Cruikshank, MK | 1 |
| Sano, I | 5 |
| Taniguchi, K | 1 |
| Leeton, J | 1 |
| van den Burg, W | 1 |
| Bos, ER | 1 |
| Dols, LC | 2 |
| Schut, T | 1 |
| Lapin, IP | 1 |
| Airaksinen, MM | 1 |
| McIsaac, WM | 1 |
| van Woudenberg, F | 1 |
| Coppen, AJ | 1 |
| Robie, TR | 1 |
| Dewhurst, WG | 1 |
18 reviews available for 5-hydroxytryptophan and Depression
| Article | Year |
|---|---|
Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis.
Topics: 5-Hydroxytryptophan; Antidepressive Agents; Clinical Trials as Topic; Cohort Studies; Cross-Sectiona | 2020 |
In brief: 5-HTP for depression.
Topics: 5-Hydroxytryptophan; Animals; Depression; Humans; Treatment Outcome | 2012 |
Review of the implications of dietary tryptophan intake in patients with irritable bowel syndrome and psychiatric disorders.
Topics: 5-Hydroxytryptophan; Depression; Diet; Digestive System; Humans; Irritable Bowel Syndrome; Molecular | 2003 |
Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Depression; Humans; Randomized Controlled Trial | 2006 |
Central serotonin deficiency--a factor which increases depression vulnerability?
Topics: 5-Hydroxytryptophan; Adult; Biogenic Amines; Brain Chemistry; Clomipramine; Depression; Female; Huma | 1980 |
Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
Topics: 5-Hydroxytryptophan; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depr | 1984 |
Tyrosine for the treatment of depression.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; D | 1984 |
Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
Topics: 5-Hydroxytryptophan; Carboxy-Lyases; Clinical Trials as Topic; Depression; Double-Blind Method; Drug | 1980 |
Use of neurotransmitter precursors for treatment of depression.
Topics: 5-Hydroxytryptophan; Depression; Humans; Phenylalanine; Tryptophan; Tyrosine | 2000 |
Tryptophan and 5-hydroxytryptophan for depression.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Second-Generation; Depression; Humans; Randomized Contro | 2001 |
Tryptophan and 5-hydroxytryptophan for depression.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Second-Generation; Depression; Humans; Randomized Contro | 2002 |
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar | 1976 |
Theoretical and therapeutic potential of indoleamine precursors. (5).
Topics: 5-Hydroxytryptophan; Depression; Female; Humans; Serotonin; Tryptamines; Tryptophan | 1977 |
[Depression and serotonin metabolism].
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Tricyclic; Brain; Depression; Female; Humans; L | 1978 |
Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology.
Topics: 5-Hydroxytryptophan; Aggression; Biology; Depression; Depressive Disorder; Humans; Mental Disorders; | 1990 |
Indoleamines in depression and suicide.
Topics: 5-Hydroxytryptophan; Brain; Celiac Disease; Depression; Humans; Parkinson Disease; Serotonin; Suicid | 1986 |
Kynurenines as probable participants of depression.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Behavior; Blood Pressure; Body Temperature; Depression; D | 1973 |
Indolealkylamines and behavior.
Topics: 5-Hydroxytryptophan; Alkaloids; Amines; Animals; Behavior; Brain; Brain Chemistry; Cats; Chemical Ph | 1968 |
17 trials available for 5-hydroxytryptophan and Depression
| Article | Year |
|---|---|
Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding.
Topics: 5-Hydroxytryptophan; Aged; Apathy; Cross-Over Studies; Depression; Double-Blind Method; Female; Huma | 2020 |
L-5HTP treatment in primary headaches: an attempt at clinical identification of responsive patients.
Topics: 5-Hydroxytryptophan; Adult; Anxiety; Chronic Disease; Clinical Trials as Topic; Depression; Female; | 1984 |
Tyrosine for the treatment of depression.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; D | 1984 |
Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
Topics: 5-Hydroxytryptophan; Carboxy-Lyases; Clinical Trials as Topic; Depression; Double-Blind Method; Drug | 1980 |
Studies on pituitary hormones and releasing hormones in depression and sexual impotence.
Topics: 5-Hydroxytryptophan; Benserazide; Bipolar Disorder; Clinical Trials as Topic; Depression; Erectile D | 1975 |
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar | 1976 |
The indoleamine hypothesis of depression: an overview and pilot study.
Topics: 5-Hydroxytryptophan; Adult; Aged; Carbidopa; Clinical Trials as Topic; Depression; Female; Homovanil | 1977 |
Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Clinical Trials | 1977 |
The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Synergis | 1977 |
L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review.
Topics: 5-Hydroxytryptophan; Antidepressive Agents; Clinical Trials as Topic; Depression; Drug Evaluation; H | 1978 |
5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depression; Drug Therapy, Combination; Female; | 1976 |
Tryptophan, 5-hydroxytryptophan and tricyclic antidepressants in the treatment of depression.
Topics: 5-Hydroxytryptophan; Catecholamines; Clinical Trials as Topic; Clomipramine; Depression; Depression, | 1976 |
Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
Topics: 5-Hydroxytryptophan; Aged; Clinical Trials as Topic; Depression; Dihydroergotoxine; Double-Blind Met | 1987 |
A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant.
Topics: 5-Hydroxytryptophan; Brain; Clinical Trials as Topic; Depression; Humans; Placebos; Probenecid; Sero | 1972 |
5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
Topics: 5-Hydroxytryptophan; Biological Transport; Brain; Brain Chemistry; Clinical Trials as Topic; Depress | 1974 |
Serotonin metabolism in depression: clinical application of the probenecid test.
Topics: 5-Hydroxytryptophan; Adjustment Disorders; Administration, Oral; Clinical Trials as Topic; Depressio | 1974 |
Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man.
Topics: 5-Hydroxytryptophan; Amphetamine; Antidepressive Agents; Brain; Carbon Isotopes; Clinical Trials as | 1970 |
65 other studies available for 5-hydroxytryptophan and Depression
| Article | Year |
|---|---|
β-carboline-independent antidepressant-like effect of the standardized extract of the barks of
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Carbolines; Depression; Harmine; Humans; Mice; | 2022 |
Octopamine mediates sugar relief from a chronic-stress-induced depression-like state in Drosophila.
Topics: 5-Hydroxytryptophan; Animals; Depression; Depressive Disorder, Major; Dopaminergic Neurons; Drosophi | 2022 |
Whey protein isolate attenuates depression-like behavior developed in a mouse model of breast tumor.
Topics: 5-Hydroxytryptophan; Animals; Depression; Female; Kynurenine; Mice; Serotonin; Tryptophan; Whey Prot | 2023 |
Metabolomic markers of antepartum depression and suicidal ideation.
Topics: 5-Hydroxytryptophan; Adult; Betaine; Biomarkers; Carnitine; Citrulline; Cross-Sectional Studies; Dep | 2020 |
Changes in Gut Microbiota by Chronic Stress Impair the Efficacy of Fluoxetine.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Cell Differentiation; Chronic Disease; Depressi | 2020 |
Serotonin modulates a depression-like state in Drosophila responsive to lithium treatment.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Brain; Cyclic AMP; Depression; Drosophila melan | 2017 |
Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Bifidobacterium; Butyrates; Depression; Dysbiosis; F | 2019 |
Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.
Topics: 5-Hydroxytryptophan; Animals; Constipation; Delayed-Action Preparations; Depression; Disease Models, | 2019 |
Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Behavior, Animal; Coptis; Corpus Striatum; Depr | 2013 |
Synthesis of 2´-hydroxy-4´-isoprenyloxychalcone derivatives with potential antidepressant-like activity.
Topics: 5-Hydroxytryptophan; Administration, Oral; Animals; Antidepressive Agents; Chalcones; Depression; Ex | 2014 |
[Serotoninergic syndrome due to interaction between linezolid and 5-hydroxytryptophan].
Topics: 5-Hydroxytryptophan; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Depression; Di | 2015 |
Integrated theory to unify status among schizophrenia and manic depressive illness.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Dis | 2015 |
1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behav | 2009 |
Implication of 5-HT(2B) receptors in the serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Explor | 2011 |
Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anxiety; Apomorphine; Arecoline; Clonidine; Depression; D | 2011 |
Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative - an investigation using behavioral tests battery of depression.
Topics: 5-Hydroxytryptophan; Acetamides; Animals; Antidepressive Agents; Behavior; Depression; Disease Model | 2011 |
Relief of depression within one day using an M.A.O. inhibitor and intravenous 5-HTP.
Topics: 5-Hydroxytryptophan; Depression; Depressive Disorder; Humans; Indoles; Monoamine Oxidase Inhibitors | 1963 |
FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP.
Topics: 5-Hydroxytryptophan; Biomedical Research; Depression; Depressive Disorder; Drug Therapy; Geriatrics; | 1964 |
CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION.
Topics: 5-Hydroxytryptophan; Amino Acids; Depression; Depressive Disorder; Humans | 1965 |
Are SAMe and 5-HTP safe and effective treatments for depression?
Topics: 5-Hydroxytryptophan; Anti-Inflammatory Agents; Antidepressive Agents; Depression; Humans; Male; Midd | 2003 |
5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin.
Topics: 5-Hydroxytryptophan; Antiviral Agents; Brain Chemistry; Depression; Drug Synergism; Drug Therapy, Co | 2005 |
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; | 2008 |
Depression vulnerability and 5-hydroxytryptophan prophylaxis.
Topics: 5-Hydroxytryptophan; Adult; Brain; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Middl | 1980 |
[Serotonin precursors as antidepressive agents: a review].
Topics: 5-Hydroxytryptophan; Climacteric; Depression; Depressive Disorder; Female; Humans; Tryptophan | 1983 |
Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Depression; Disease Models, Animal; Humans; Male; Methy | 1984 |
Hormone response to 5-HTP: a reply.
Topics: 5-Hydroxytryptophan; Depression; Growth Hormone; Humans; Hydrocortisone; Prolactin | 1984 |
[Central serotonin metabolism in depression].
Topics: 5-Hydroxytryptophan; Affect; Brain; Depression; Humans; Longitudinal Studies; Probenecid; Serotonin; | 1980 |
l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.
Topics: 5-Hydroxytryptophan; Adult; Age Factors; Aged; Antidepressive Agents; Carbidopa; Depression; Drug Re | 1980 |
Pre- and postsynaptic serotonergic manipulations in an animal model of depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Depression; Disease Models, Animal; Drug Synergism; Flu | 1980 |
[Open study of L-5-H.T.P. in melancholic depressed patients over 50 years of age (author's transl)].
Topics: 5-Hydroxytryptophan; Aged; Depression; Drug Evaluation; Female; Humans; Male; Middle Aged | 1980 |
Postsynaptic action by four antidepressive drugs in an animal model of depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Di | 1981 |
Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain Chemistry; Cerebral Cort | 1994 |
Letter: L 5-Hydroxytryptophan and mood.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Aggression; Brain Neoplasms; Depression; Dose-Response Rela | 1975 |
Animal model of depression. III. Mechanism of action of tetrabenazine.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Depression; Disease Models, Animal; Dopamine; | 1978 |
The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Autopsy; Bipolar Disorder; Brain Chemistry; C | 1977 |
Theoretical and therapeutic potential of indolamine precursors in affective disorders.
Topics: 5-Hydroxytryptophan; Amino Acids; Bipolar Disorder; Depression; Emotions; Female; Humans; Levodopa; | 1977 |
[L-5-hydroxytryptophan treatment of depression].
Topics: 5-Hydroxytryptophan; Depression; Humans | 1978 |
Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression.
Topics: 5-Hydroxytryptophan; Aged; Biogenic Amines; Depression; Female; Humans; Isoproterenol; Male; Middle | 1977 |
Effect of l-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients.
Topics: 5-Hydroxytryptophan; Adjustment Disorders; Adult; Aged; Blood Platelets; Brain; Depression; Female; | 1975 |
The effect of tryptophan and a tryptophan/5-hydroxytryptophan combination on indoles in the brains of rats fed a tryptophan deficient diet.
Topics: 3-Hydroxyanthranilic Acid; 5-Hydroxytryptophan; Animals; Brain; Depression; Diet; Drug Synergism; Hu | 1975 |
Central monoamine deficiency in depressions: causative of secondary phenomenon?
Topics: 5-Hydroxytryptophan; Clomipramine; Depression; Dopamine; Homovanillic Acid; Humans; Serotonin | 1975 |
Theoretical and therapeutic potential of indoleamine precursors. (1). Introduction.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Animals; Biogenic Amines; Depression; Diagnosis, Differenti | 1976 |
Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; | 1976 |
Reduction of blood platelet serotonin levels in manic and depressed patients.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Bipolar Disorder; Blood Platelets; Depression; Female; | 1976 |
Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adolescent; Adult; Depression; Female; Humans; Hydroxyind | 1976 |
Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Aged; Carbidopa; Chronic Disease; Depression; Drug Therapy, Combination; Eosino | 1991 |
[Current status, perspectives and limitations of serotonin precursors].
Topics: 5-Hydroxytryptophan; Central Nervous System; Depression; Humans; Serotonin; Sleep; Tryptophan | 1990 |
Pineal melatonin functions and the depression of Parkinson's disease: a hypothesis.
Topics: 5-Hydroxytryptophan; Animals; Depression; Dopamine; Humans; Melatonin; Models, Neurological; Parkins | 1990 |
Amperozide and emotional behaviour.
Topics: 5-Hydroxytryptophan; Aggression; Animals; Behavior, Animal; Blepharoptosis; Conflict, Psychological; | 1990 |
Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Conditioning, Operant; Depression; Male; Rats; | 1986 |
Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
Topics: 5-Hydroxytryptophan; Animals; Depression; Disease Models, Animal; Drug Synergism; Male; Rats; Rats, | 1987 |
Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857).
Topics: 5-Hydroxytryptophan; Animals; Cerebral Cortex; Conditioning, Operant; Depression; Desipramine; Disea | 1985 |
5-hydroxytryptophan for depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Depression; Dihydroxyphenylalanine; Electroconvulsive Therapy; H | 1967 |
Subtype of affective psychoses classified by response on amineprecursors and monoamine metabolism.
Topics: 5-Hydroxytryptophan; Amines; Depression; Dihydroxyphenylalanine; Female; Humans; Hydroxyindoleacetic | 1974 |
Pharmacological and biochemical correlates of 5-hydroxytryptamine entry into the central nervous system during maturation.
Topics: 5-Hydroxytryptophan; Age Factors; Animals; Brain Chemistry; Cerebellum; Chickens; Depression; Dience | 1968 |
[L-5-hydroxytryptophan-(L-5-HTP) therapy].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Antidepressive Agents; Child; Depression; Female; Huma | 1972 |
[L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1].
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzoates; Bipolar Disorder; Child; Depression; Female | 1972 |
[L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
Topics: 5-Hydroxytryptophan; Adult; Aged; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle A | 1972 |
[Treatment of endogenous depression with L-hydroxy-tryptophan (L-5-HTP)].
Topics: 5-Hydroxytryptophan; Aged; Depression; Humans; Isomerism; Male; Middle Aged | 1973 |
Depression induced by oral contraception and the role of vitamin B6 in its management.
Topics: 5-Hydroxytryptophan; Contraceptives, Oral; Depression; Female; Humans; Pyridoxine; Serotonin; Trypto | 1974 |
5-hydroxytryptophan in combination with clomipramine in "therapy-resistant" depressions.
Topics: 5-Hydroxytryptophan; Adult; Antidepressive Agents; Carboxy-Lyases; Depression; Dibenzazepines; Drug | 1974 |
Depressed states and indolealkylamines.
Topics: 5-Hydroxytryptophan; Carbon Isotopes; Catecholamines; Depression; Humans; Indoles; Middle Aged; Mono | 1968 |
Crash treatment for melancholia. Resistant to other recently developed methods.
Topics: 5-Hydroxytryptophan; Adult; Aged; Antidepressive Agents; Blood Pressure Determination; Depression; D | 1970 |
Tryptophan pyrrolase and depressive illness.
Topics: 5-Hydroxytryptophan; Depression; Humans; Hydroxyindoleacetic Acid; Psychiatric Status Rating Scales; | 1970 |
["Precursor therapy" with active amines. I. Treatment of depression by L-5-HTP (L-5-hydroxytryptophan)].
Topics: 5-Hydroxytryptophan; Adult; Aged; Depression; Female; Gastrointestinal Diseases; Humans; Male; Middl | 1971 |